{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:21:50Z","timestamp":1781306510512,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Advances in research suggest the possibility of improving routine clinical care for preeclampsia using screening (predictive) and diagnostic tests. The views of women should be incorporated into the way in which such tests are used. Therefore, we explored the views of women with experience of preeclampsia and other hypertensive disorders in pregnancy (HDPs) about predictive and diagnostic tests, treatment risks, and expectant management.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>Eight hundred and seven women with experience of preeclampsia or other HDPs completed an online questionnaire. These women were participants in the Preeclampsia Registry (USA). The questionnaire contained 22 items to elicit women\u2019s views about predictive tests (<jats:italic>n<\/jats:italic>\u00a0=\u20098); diagnostic tests (<jats:italic>n<\/jats:italic>\u00a0=\u20095); treatment risks (<jats:italic>n<\/jats:italic>\u00a0=\u20097), and expectant management (<jats:italic>n<\/jats:italic>\u00a0=\u20092). An optional text box allowed participants to add qualitative open-ended comments. Levels of agreement with the statements were reported descriptively for the sample as a whole, and a preliminary investigation of the role of lived experience in shaping women\u2019s views was conducted by comparing subgroups within the sample based on time of HDP delivery (preterm\/term). The qualitative data provided in the optional text box was analysed using inductive thematic analysis to examine participants\u2019 responses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Women generally favored predictive and diagnostic testing, although not because they would opt for termination of pregnancy. Participants generally disagreed that taking daily low-dose aspirin (LDA) would make them nervous, with disagreement significantly higher in the preterm delivery subgroup. A high proportion of participants, especially in the preterm delivery subgroup, would take LDA throughout pregnancy. The majority of participants would be more worried about the possibility of preeclampsia than about the risks of treatments to their health (60%), and that proportion was significantly higher in the preterm delivery subgroup. There were no differences between subgroups in the views expressed about expectant management, although opinion was divided in both groups. Overall, most participants opted to put the baby\u2019s interests first.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Women with experience of hypertensive disorders were enthusiastic about improved predictive and diagnostic tests. However, varied views about treatment options and expectant management suggest the need for a shared decision-making tool to enable healthcare professionals to support pregnant women\u2019s decision-making to maximize the utility of these tests and interventions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-021-04144-2","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T13:03:44Z","timestamp":1633007024000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Women\u2019s attitudes, beliefs and values about tests, and management for hypertensive disorders of pregnancy"],"prefix":"10.1186","volume":"21","author":[{"given":"Shenaz","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni Z.","family":"Tsigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryn","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Chappell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Hewison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"key":"4144_CR1","first-page":"7","volume":"8","author":"FA English","year":"2015","unstructured":"English FA, Kenny LC, McCarthy FP. Risk factors and effective management of preeclampsia. Integr Blood Press Control. 2015;8:7\u201312.","journal-title":"Integr Blood Press Control"},{"issue":"4","key":"4144_CR2","first-page":"329","volume":"33","author":"T Shih","year":"2016","unstructured":"Shih T, Peneva D, Xu X, et al. The rising burden of preeclampsia in the United States impacts both maternal and child health. Am J Perinatol. 2016;33(4):329\u201338.","journal-title":"Am J Perinatol"},{"issue":"5","key":"4144_CR3","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","volume":"122","author":"Hypertension in pregnancy","year":"2013","unstructured":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122\u201331.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"4144_CR4","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1097\/AOG.0b013e3181a45b25","volume":"113","author":"EV Kuklina","year":"2009","unstructured":"Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol. 2009;113(6):1299\u2013306.","journal-title":"Obstet Gynecol"},{"issue":"8","key":"4144_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11906-020-01058-w","volume":"22","author":"V Katsi","year":"2020","unstructured":"Katsi V, Skalis G, Vamvakou G, Tousoulis D, Makris T. Postpartum Hypertension. Curr Hypertens Rep. 2020;22(8):58.","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"4144_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/uog.21869","volume":"55","author":"LC Poon","year":"2020","unstructured":"Poon LC, Galindo A, Surbek D, et al. From first-trimester screening to risk stratification of evolving pre-eclampsia in second and third trimesters of pregnancy: comprehensive approach. Ultrasound Obstet Gynecol. 2020;55(1):5\u201312.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"10","key":"4144_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.7326\/M13-2844","volume":"160","author":"JT Henderson","year":"2014","unstructured":"Henderson JT, Whitlock EP, O'Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. preventive services task force. Ann Intern Med. 2014;160(10):695\u2013703.","journal-title":"Ann Intern Med"},{"issue":"9741","key":"4144_CR8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","volume":"376","author":"EA Steegers","year":"2010","unstructured":"Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631\u201344.","journal-title":"Lancet."},{"issue":"3","key":"4144_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3109\/10641955.2016.1167219","volume":"35","author":"LB Andersen","year":"2016","unstructured":"Andersen LB, Dechend R, Jorgensen JS, et al. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense child cohort. Hypertens Pregnancy. 2016;35(3):405\u201319.","journal-title":"Hypertens Pregnancy"},{"issue":"7","key":"4144_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181468","volume":"12","author":"O Erez","year":"2017","unstructured":"Erez O, Romero R, Maymon E, et al. The prediction of late-onset preeclampsia: results from a longitudinal proteomics study. PLoS One. 2017;12(7):e0181468.","journal-title":"PLoS One"},{"issue":"3","key":"4144_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1515\/cclm-2019-0939","volume":"58","author":"P Lafuente-Ganuza","year":"2020","unstructured":"Lafuente-Ganuza P, Lequerica-Fernandez P, Carretero F, et al. A more accurate prediction to rule in and rule out pre-eclampsia using the sFlt-1\/PlGF ratio and NT-proBNP as biomarkers. Clin Chem Lab Med. 2020;58(3):399\u2013407.","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"4144_CR12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/HYPERTENSIONAHA.116.08620","volume":"69","author":"U Sovio","year":"2017","unstructured":"Sovio U, Gaccioli F, Cook E, Hund M, Charnock-Jones DS, Smith GC. Prediction of preeclampsia using the soluble fms-like tyrosine kinase 1 to placental growth factor ratio: a prospective cohort study of unselected nulliparous women. Hypertension. 2017;69(4):731\u20138.","journal-title":"Hypertension."},{"issue":"9694","key":"4144_CR13","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0140-6736(09)60736-4","volume":"374","author":"CM Koopmans","year":"2009","unstructured":"Koopmans CM, Bijlenga D, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374(9694):979\u201388.","journal-title":"Lancet."},{"issue":"4","key":"4144_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4258\/hir.2014.20.4.266","volume":"20","author":"A Aslani","year":"2014","unstructured":"Aslani A, Tara F, Ghalighi L, et al. Impact of computer-based pregnancy-induced hypertension and diabetes decision AIDS on empowering pregnant women. Healthc Inform Res. 2014;20(4):266\u201371.","journal-title":"Healthc Inform Res"},{"key":"4144_CR15","doi-asserted-by":"publisher","DOI":"10.4135\/9781412963947","volume-title":"Encyclopedia of survey research methods","author":"PJ Lavrakas","year":"2008","unstructured":"Lavrakas PJ. Encyclopedia of survey research methods. Thousand Oaks: SAGE Publications, Inc; 2008."},{"issue":"21","key":"4144_CR16","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1161\/CIRCULATIONAHA.117.031527","volume":"138","author":"HS Gammill","year":"2018","unstructured":"Gammill HS, Chettier R, Brewer A, et al. Cardiomyopathy and preeclampsia. Circulation. 2018;138(21):2359\u201366.","journal-title":"Circulation."},{"issue":"10204","key":"4144_CR17","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S0140-6736(19)31963-4","volume":"394","author":"LC Chappell","year":"2019","unstructured":"Chappell LC, Brocklehurst P, Green ME, et al. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial. Lancet. 2019;394(10204):1181\u201390.","journal-title":"Lancet."},{"issue":"1","key":"4144_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12884-016-1195-2","volume":"17","author":"NM Crombag","year":"2017","unstructured":"Crombag NM, Lamain-de Ruiter M, Kwee A, et al. Perspectives, preferences and needs regarding early prediction of preeclampsia in Dutch pregnant women: a qualitative study. BMC Pregnancy Childbirth. 2017;17(1):12.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"12","key":"4144_CR19","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.midw.2014.04.006","volume":"30","author":"JM Harris","year":"2014","unstructured":"Harris JM, Franck L, Green B, Michie S. The psychological impact of providing women with risk information for pre-eclampsia: a qualitative study. Midwifery. 2014;30(12):1187\u201395.","journal-title":"Midwifery."},{"issue":"1","key":"4144_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228196","volume":"15","author":"D Coates","year":"2020","unstructured":"Coates D, Makris A, Catling C, et al. A systematic scoping review of clinical indications for induction of labour. PLoS One. 2020;15(1):e0228196.","journal-title":"PLoS One"},{"issue":"1","key":"4144_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12978-019-0707-8","volume":"16","author":"A Vestering","year":"2019","unstructured":"Vestering A, Bekker MN, Grobbee DE, et al. Views and preferences of medical professionals and pregnant women about a novel primary prevention intervention for hypertensive disorders of pregnancy: a qualitative study. Reprod Health. 2019;16(1):46.","journal-title":"Reprod Health"},{"issue":"2","key":"4144_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11906-020-1026-8","volume":"22","author":"M Ma'ayeh","year":"2020","unstructured":"Ma'ayeh M, Rood KM, Kniss D, Costantine MM. Novel interventions for the prevention of preeclampsia. Curr Hypertens Rep. 2020;22(2):17.","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"4144_CR23","doi-asserted-by":"publisher","first-page":"141.e141","DOI":"10.1016\/j.ajog.2016.09.086","volume":"216","author":"F Mone","year":"2017","unstructured":"Mone F, Mulcahy C, McParland P, McAuliffe FM. Should we recommend universal aspirin for all pregnant women? Am J Obstet Gynecol. 2017;216(2):141.e141\u20135.","journal-title":"Am J Obstet Gynecol"},{"key":"4144_CR24","doi-asserted-by":"publisher","first-page":"375653","DOI":"10.1155\/2011\/375653","volume":"2011","author":"C East","year":"2011","unstructured":"East C, Conway K, Pollock W, Frawley N, Brennecke S. Women's experiences of preeclampsia: Australian action on preeclampsia survey of women and their confidants. J Pregnancy. 2011;2011:375653.","journal-title":"J Pregnancy"},{"issue":"4","key":"4144_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/birt.12003","volume":"39","author":"JM Green","year":"2012","unstructured":"Green JM. Integrating women's views into maternity care research and practice. Birth. 2012;39(4):291\u20135.","journal-title":"Birth."},{"issue":"1","key":"4144_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1258\/om.2008.070001","volume":"1","author":"N Sauv\u00e9","year":"2008","unstructured":"Sauv\u00e9 N, Powrie RO, Larson L, et al. The impact of an educational pamphlet on knowledge and anxiety in women with preeclampsia. Obstet Med. 2008;1(1):11\u20137.","journal-title":"Obstet Med"},{"key":"4144_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14767058.2020.1786524","volume":"6","author":"ER Strassberg","year":"2020","unstructured":"Strassberg ER, Fisher S, Mackeen AD, Sun H, Paglia MJ. Comparison of different methods of patient education on preeclampsia: a randomized controlled trial. J Matern Fetal Neonatal Med. 2020;6:1\u20135.","journal-title":"J Matern Fetal Neonatal Med"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04144-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-021-04144-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04144-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T13:03:49Z","timestamp":1633007029000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-04144-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4144"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-04144-2","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]},"assertion":[{"value":"17 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the experiment protocol for involving humans was in accordance to guidelines of the Declaration of Helsinki. Study protocols regarding human subjects were approved by the Advarra Institutional Review Board (IRB), a private independent IRB (). Informed consent was obtained on-line from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"665"}}